This results showed that although CNS nesfatin-1 did not directly affect NAFLD, it could regulate the expression of peripheral nesfatin-1, i.e. gastric nesfatin-1. This evidence concerns the gene NUCB2 and metabolic dysfunction-associated steatotic liver disease.